A stronger-than-expected reading on the labor market coupled with a solid reading on American spending turned the direction of the U.S. debt market. Private employers added 62,000 jobs in March, ...
The human resources and payroll giant tapped CBRE Senior Vice President David Wigoda to market the 28-year-old, two-story office building in Kendall, according to a marketing brochure. The nearly ...
The authors note that, due to a production error, Fig. 2 and Fig. 3 appeared incorrectly. The authors explain that at proofs, Fig. 2 was mistakenly replaced by the updated Fig. 3. As a result, Fig. 2 ...
2026 Fantasy Baseball ADP Risers: 3 key players boosting their stock as spring training nears an end
There’s less than 10 days until the start of the 2026 MLB season and it’s likely almost time for your fantasy baseball draft. Of course, there’s no reason to overreact to spring training performances ...
ADP is partnering with Ema to help launch purpose-built AI agents across multiple HCM platforms that will solve key pain points for HR and payroll practitioners. Ema's platform delivers the enterprise ...
ADP (ADP) raised its quarterly dividend by 10% to $1.70 per share. This marks ADP’s 50th consecutive year of dividend increases. ADP generated $4.8B in free cash flow against $2.4B in dividend ...
The offseason is over, spring training is here, and injury news is already flooding our news feeds. With that, we’re starting to get the first big swings in ADP data of draft season. Here are the ...
Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. This voice experience is generated by AI. Learn more. This ...
ROSELAND, N.J. – ADP, the human capital management company with offices in the Lehigh Valley and Fort Washington, reported its second quarter results of fiscal year 2026 and beat stock analysts’ ...
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...
This important study presents the development of a novel inhibitor for SARS-CoV-2 Mac1 that has potential utility both as an antiviral therapeutic and as a tool for probing the molecular mechanisms by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results